CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
▲ 0 upgrades / ▼ 0 downgrades / 2 reiterations from 2 firms
Nov 4, 2026 (9 days)
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 13, 2026 | Morgan Stanley | maintain | Overweight → Overweight | — | 54% |
| Sep 28, 2026 | Jefferies | maintain | Buy → Buy | — | 52% |
| Sep 25, 2026 | Deutsche Bank | maintain | Buy → Buy | — | 57% |
| Sep 25, 2026 | TD Cowen | maintain | Buy → Buy | — | 54% |
| Sep 25, 2026 | Evercore ISI Group | maintain | Outperform → Outperform | — | 58% |
| Sep 25, 2026 | RBC Capital | maintain | Outperform → Outperform | — | 55% |
| Sep 25, 2026 | Barclays | maintain | Overweight → Overweight | — | 53% |
| Sep 25, 2026 | Mizuho | maintain | Neutral → Neutral | — | 52% |
| Sep 25, 2026 | Baird | maintain | Outperform → Outperform | — | 55% |
| Sep 11, 2026 | Evercore ISI Group | maintain | Outperform → Outperform | — | 58% |
| Aug 10, 2026 | TD Cowen | maintain | Buy → Buy | — | 54% |
| Aug 7, 2026 | Morgan Stanley | maintain | Overweight → Overweight | — | 54% |
| Aug 6, 2026 | RBC Capital | maintain | Outperform → Outperform | — | 55% |
| Aug 6, 2026 | Evercore ISI Group | maintain | Outperform → Outperform | — | 58% |
| Aug 6, 2026 | JP Morgan | upgrade | Neutral → Overweight | — | 54% |
| Jul 20, 2026 | CLSA | downgrade | Outperform → Hold | — | 50% |
| Jul 13, 2026 | Mizuho | maintain | Neutral → Neutral | — | 52% |
| Jul 9, 2026 | Morgan Stanley | maintain | Overweight → Overweight | — | 54% |
| Jun 17, 2026 | Morgan Stanley | upgrade | Equal-Weight → Overweight | — | 54% |
| May 29, 2026 | CLSA | upgrade | Hold → Outperform | — | 50% |
| May 8, 2026 | Barclays | maintain | Overweight → Overweight | — | 53% |
| May 8, 2026 | Evercore ISI Group | maintain | Outperform → Outperform | — | 58% |
| Apr 14, 2026 | Barclays | maintain | Overweight → Overweight | — | 53% |
| Apr 13, 2026 | JP Morgan | maintain | Neutral → Neutral | — | 54% |
| Feb 25, 2026 | UBS | maintain | Neutral → Neutral | $175 | 54% |
| Feb 20, 2026 | TD Cowen | maintain | Buy → Buy | $235 | 54% |
| Feb 20, 2026 | Mizuho | maintain | Neutral → Neutral | $175 | 52% |
| Feb 19, 2026 | Barclays | maintain | Overweight → Overweight | $200 | 53% |
| Feb 19, 2026 | Evercore ISI Group | maintain | Outperform → Outperform | $200 | 58% |
| Jan 16, 2026 | Citigroup | maintain | Buy → Buy | $265 | 54% |
| Jan 13, 2026 | Evercore ISI Group | maintain | Outperform → Outperform | $260 | 58% |
| Dec 18, 2025 | Mizuho | maintain | Neutral → Neutral | $200 | 52% |
| Dec 15, 2025 | Barclays | maintain | Overweight → Overweight | $215 | 53% |
| Dec 15, 2025 | JP Morgan | maintain | Neutral → Neutral | $190 | 54% |
| Nov 11, 2025 | Morgan Stanley | maintain | Equal-Weight → Equal-Weight | $185 | 54% |
| Nov 10, 2025 | TD Cowen | maintain | Buy → Buy | $197 | 54% |
| Nov 6, 2025 | JP Morgan | maintain | Neutral → Neutral | $165 | 54% |
| Nov 6, 2025 | Barclays | maintain | Overweight → Overweight | $210 | 53% |
| Nov 6, 2025 | Baird | upgrade | Neutral → Outperform | $199 | 55% |
| Oct 17, 2025 | Mizuho | maintain | Neutral → Neutral | $174 | 52% |
| Oct 6, 2025 | William Blair | upgrade | Market Perform → Outperform | $0 | 48% |
| Oct 3, 2025 | Evercore ISI Group | maintain | Outperform → Outperform | $200 | 58% |
| Oct 2, 2025 | Barclays | upgrade | Equal-Weight → Overweight | $195 | 53% |
| Sep 9, 2025 | Jefferies | upgrade | Hold → Buy | $195 | 52% |
| Aug 8, 2025 | Evercore ISI Group | maintain | Outperform → Outperform | $190 | 58% |
| Aug 7, 2025 | JP Morgan | maintain | Neutral → Neutral | $160 | 54% |
| Aug 7, 2025 | Barclays | maintain | Equal-Weight → Equal-Weight | $165 | 53% |
| Jul 9, 2025 | Evercore ISI Group | maintain | Outperform → Outperform | $180 | 58% |
| Jul 9, 2025 | Citigroup | upgrade | Neutral → Buy | $200 | 54% |
| May 23, 2025 | Redburn Atlantic | upgrade | Neutral → Buy | $182 | 49% |
No cross-platform signals in the last 90 days